S. 229In Committee
DTC Act of 2025
Plain-English overview
What this bill does
Requires certain prescription drug and biologic ads covered by Medicare or Medicaid to clearly disclose 30 day wholesale prices for consumers
Key points
- Require wholesale price disclosures
- Authorize civil penalties
- Limit requirement to higher cost ads
- Allow insurance cost explanation
Current status
Where it stands
Status
In Committee
Latest action
2025-01-23 — Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.
